Grants and Contributions:
Agreement Number:
-
Agreement Value:
$279,226.00
Agreement Date:
Apr 1, 2018 - Mar 31, 2020
Description:
Démonstration de l'efficacité du premier inhibiteur irréversible et sélectif de la 17beta-HSD1 pour le traitement des cancers du sein sensibles aux estrogènes
Organization:
Canadian Institutes of Health Research
Location:
Québec, Quebec, CA G1K 7P4
Reference Number:
236-2017-2018-Q4-00478
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:
Grant or Award spanning more than one fiscal year.
(2018-19 to 2019-20)
Recipient's Legal Name:
Poirier, Donald
Research Organization:
Université Laval